OakChart

Apimeds Pharmaceuticals US Inc

APUSHealthcare·Drug Manufacturers - Specialty & Generic·USA·Nano·AMEX·Nov 12 • 3:58 PM ET

2.27-0.09 (-3.81%)
2026-11-13 13:01 CET
Market cap
$3.43M
Revenue, TTM
0.00 USD m
Net income, TTM
-58.17 USD m
Free cash flow, TTM
-13.92 USD m
EPS diluted, TTM
-36.71
Price / earnings
-
Compare

Price

APUS against its 20, 50 and 200-day averages
Terms2050200
Patternshover a marker to name it
RS 25.0010.0015.0043.9M87.8MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26APUSclose 2.2720-day 2.9950-day 3.44200-day 10.082.27

96.2% under the 52-week high of 59.70 on 5 May 2026. 52-week low 1.51 on 16 Sep 2026. Last 15 sessions, 46.8% high to low

Volume 0.00× normal · the session has not printed · the line is the 50-bar volume average

Setup. RS line 2
CANSLIM 1 of 6 — fails: EPS Growth Qtr Over Qtr: High (>25%); 52-Week High/Low: 0-10% below High; Performance: Year +50%; Institutional Ownership: Over 50% — not on the tape: EPS Growth This Year: High (>25%)
VCP 3 of 6 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High
Minervini 0 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 0 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5; 200-Day Simple Moving Average: Price above SMA200
Leaders 1 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%; 52-Week High/Low: 0-10% below High
Breakout 0 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200
Growth 0 of 4 — fails: EPS Growth Qtr Over Qtr: High (>25%); Return on Equity: Over +15% — not on the tape: EPS Growth This Year: High (>25%); EPS Growth Next Year: High (>25%)
Quality 0 of 5 — fails: Return on Equity: Over +15%; Debt/Equity: Low (<0.1); Current Ratio: Over 1 — not on the tape: Net Profit Margin: High (>20%); P/E: Under 25
Value 1 of 4 — fails: Return on Equity: Over +15%; Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 2 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%
Accumulation 0 of 4 — fails: Institutional Ownership: Over 30%; 200-Day Simple Moving Average: Price above SMA200; Performance: Year Up — not on the tape: Institutional Transactions: Over +10%
Relative Strength 1 of 3 — fails: Performance: Year +100%; 200-Day Simple Moving Average: Price above SMA200

Profile

APUS
52-week range, 1% of the way up
1.5159.70

Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. It primarily focuses on developing innovative therapies for inflammation and pain management in knee osteoarthritis (OA) and, to a lesser extent, multiple sclerosis (MS). The company was founded on May 11, 2020 and is headquartered in Matawan, NJ.

Employees7
IPOMay 09, 2025
Beta0.25
ATR, 14d0.56
Rel volume0.00
Short float5.68%
Insider own62.68%
Inst own2.94%

Snapshot

6 groups

Valuation

Index-
Market Cap$3.43M
Enterprise Value9.72M
Income-58.17M
Sales0.00M
Book / share70.54
Cash / share5.48
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees7
IPOMay 09, 2025

Ratios

Price / earnings-
Forward price / earnings-
Price / earnings / growth-
Price / sales-
Price / book0.03
Price / cash0.41
Price / free cash flow-
Value / cash profit-
Value / sales-
Quick Ratio0.51
Current Ratio0.51
Debt / equity0.14
Long-term debt / equity0.00
Options and shortNo / Yes

Earnings

Earnings / share-36.71
Earnings next year-
Earnings next quarter-
Earnings this year-
Earnings next year-
Earnings growth, 5 years-
Past earnings growth-108.46% -
Past sales growth- -
Earnings vs last year-1063.72%
Sales vs last year-
Earnings vs last quarter-456.18%
Sales vs last quarter-
Earnings-
Surprise- -

Ownership

Insiders own62.68%
Insider trades0.00%
Institutions own2.94%
Institution trades-
Return on assets-84.20%
Return on equity-100.13%
Return on capital-54.59%
Gross Margin-
Operating margin-
Profit Margin-
20-day average-23.98%
50-day average-34.04%
200-day average-77.47%

Technical

Shares out1.51M
Shares floating0.56M
Short / float5.68%
Short ratio0.01
Short interest0.03M
52-week high59.70 -96.2%
52-week low1.51 +50.3%
Volatility9.52% 12.35%
Average range0.56
Strength index35.11
Market sensitivity0.25
Relative volume0.00
Avg Volume3.70M
Volume0

Performance

Perf Week-16.85%
Perf Month-50.44%
Perf Quarter-50.11%
Perf Half Y-83.43%
Perf YTD-86.16%
Perf Year-91.53%
Perf 3Y-
Perf 5Y-
Perf 10Y-
Recommendation-
Target Price-
Prev Close2.27
Price2.27
Change %0.00%

Peers

Mkt cap
TickerCompanyMkt cap
NXTTNext Technology Holding Inc13.71M
NAKANakamoto Inc106.60M
ASSTStrive Inc2.74B
GNSGenius Group Ltd19.46M
MSTRStrategy Inc47.74B
SQNSSequans Communications S.A ADR36.62M
DJTTrump Media & Technology Group Corp1.40B
ABTCAmerican Bitcoin Corp366.10M
BTCSBTCS Inc46.74M
GMEGamestop Corp12.87B

Held by

AUM
TickerCompanyAUM
VXFVanguard Extended Market Index ETFAUM: 30.79B

Quarterly earnings

actual against estimate

No quarterly earnings.

Annual earnings

No annual earnings.

Quarterly results

2026Q2 revenue 0.00, from 0.00 a year earlier
Revenue, USD millions
0.890-0.892024Q3 revenue 0.0024Q32024Q4 revenue 0.0024Q42025Q1 revenue 0.0025Q12025Q2 revenue 0.0025Q22025Q3 revenue 0.0025Q32025Q4 revenue 0.0025Q42026Q1 revenue 0.0026Q12026Q2 revenue 0.0026Q2

From the quarterly statement. Not an estimate.

Estimate revisions

Latest snapshot of each period and type.

No estimate revisions.

Estimate history

Annual
Metric2022202320242025TTMMRQ
EPS per share-0.527-0.613-1.188-4.772-36.7084-
Sales USD millions00000-
Shares million shares1111-2
Quarterly
MetricQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
EPS per share-0.354-0.262-0.266-0.509-2.117-1.416-0.919-22.6-11.774
Sales USD millions000000000
Shares million shares111111112

Income statement, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/2022
Total Revenue0.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.050.010.000.000.00
Gross Profit-0.05-0.010.000.000.00
Selling, General and Administrative Excl. Other19.1911.91+830.5%1.28+70.7%0.75+17.2%0.64
Research and Development2.841.630.00-100.0%0.10-73.0%0.37
Other Operating Expense0.000.000.000.000.00
Operating Income-19.24-11.91-1.28-0.75-0.64
Interest Expense4.310.28+133.3%0.12+200.0%0.04+33.3%0.03
Unusual Expense41.23-1.890.000.000.00
Net Income Before Taxes-58.17-6.00-1.39-0.78-0.67
Income Taxes0.000.000.000.000.00
Consolidated Net Income-58.17-6.00-1.39-0.78-0.67
Net Income From Continuing Operations-58.17-6.00-1.39-0.78-0.67
Net Income-58.17-6.00-1.39-0.78-0.67
EPS (Recurring) per share-17.11-5.82-1.19-0.61-0.53
EPS (Basic, Before Extraordinaries) per share-36.71-4.77-1.19-0.61-0.53
EPS (Diluted) per share-36.71-4.77-1.19-0.61-0.53
EBITDA-19.19-11.91-1.28-0.75-0.64
Non-Operating Income (Expense)6.604.300.00-100.0%0.010.00
Other After Tax Adjustments0.000.000.000.000.00
Stock Option Compensation Expense0.332.040.00-100.0%0.07-63.2%0.19
Shares Outstanding million shares1.511.26+7.7%1.17-7.9%1.270.0%1.27
Market Capitalization3.433.43-83.4%20.62--

Income statement, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/20242024Q39/30/2024
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.020.020.000.000.000.000.000.00
Gross Profit-0.02-0.02-0.00-0.00-0.000.000.000.00
Selling, General and Administrative Excl. Other6.26+135.3%4.05+1025.0%7.04+2414.3%1.84+513.3%2.66+518.6%0.36+33.3%0.28-50.0%0.30+200.0%
Research and Development0.96+47.7%0.900.360.620.650.000.00-100.0%0.00
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-6.28-4.07-7.04-1.84-2.66-0.36-0.28-0.30
Interest Expense3.22+16000.0%0.86+2050.0%0.22+450.0%0.01-66.7%0.020.0%0.04+33.3%0.04+300.0%0.03+200.0%
Unusual Expense12.9630.14-1.87-0.01-0.010.000.000.00
Net Income Before Taxes-20.17-35.06-1.16-1.78-2.66-0.40-0.31-0.33
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-20.17-35.06-1.16-1.78-2.66-0.40-0.31-0.33
Net Income From Continuing Operations-20.17-35.06-1.16-1.78-2.66-0.40-0.31-0.33
Net Income-20.17-35.06-1.16-1.78-2.66-0.40-0.31-0.33
EPS (Recurring) per share-6.48-9.00-1.96-1.42-2.12-0.51-0.27-0.26
EPS (Basic, Before Extraordinaries) per share-11.77-22.60-0.92-1.42-2.12-0.51-0.27-0.26
EPS (Diluted) per share-11.77-22.60-0.92-1.42-2.12-0.51-0.27-0.26
EBITDA-6.26-4.05-7.04-1.84-2.66-0.36-0.28-0.30
Non-Operating Income (Expense)2.29+11350.0%0.02+666566.7%4.23+14099900.0%0.060.023E-063E-05-99.7%0.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.11-94.2%0.110.070.041.89---
Shares Outstanding million shares1.51+19.8%1.26+59.5%1.26+7.7%1.26-0.8%1.26-0.8%0.79-37.8%1.17-7.9%1.270.0%
Market Capitalization3.43-84.5%22.50+59.9%20.6222.3922.1314.07--

Balance sheet, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/2022
Cash & Short Term Investments11.640.00-100.0%0.41+4000.0%0.01
Short Term Receivables0.000.000.000.00
Inventories0.000.000.000.00
Other Current Assets2.35+23400.0%0.010.0%0.010.00
Total Current Assets13.98+139700.0%0.01-97.6%0.42+4100.0%0.01
Net Property, Plant & Equipment0.240.000.000.00
Total Investments and Advances0.000.000.000.00
Intangible Assets149.890.000.000.00
Other Assets0.080.000.000.00
Total Assets164.18+1641700.0%0.01-97.6%0.42+4100.0%0.01
Short Term Debt Incl. Current Port. of LT Debt7.63+2952.0%0.250.00-100.0%0.26
Accounts Payable0.920.000.000.00
Income Tax Payable--0.000.00
Other Current Liabilities2.16+180.5%0.77+541.7%0.12+100.0%0.06
Total Current Liabilities10.71+950.0%1.02+750.0%0.12-62.5%0.32
Long Term Debt0.13-62.9%0.35+29.6%0.27-32.5%0.40
Provision for Risks Charges0.000.000.000.00
Other Liabilities0.000.000.000.00
Total Liabilities10.84+691.2%1.37+251.3%0.39-45.8%0.72
Non-Equity Reserves0.000.000.000.00
Preferred Stock - Carrying Value0.070.000.000.00
Common Equity153.27-1.36-4633.3%0.03-0.71
Total Shareholders Equity153.35-1.36-4633.3%0.03-0.71
Accumulated Minority Interest0.000.000.000.00
Total Equity153.35-1.36-4633.3%0.03-0.71
Total Liabilities & Stockholders Equity164.18+1641700.0%0.01-97.6%0.42+4100.0%0.01
Book Value Per Share per share121.88-1.16-3966.7%0.03-0.56
Tangible Book Value Per Share per share2.69-1.16-3966.7%0.03-0.56
Full-Time Employees people7+250.0%20.0%2-
Price to Book Ratio ratio0.032.53--
Return on Assets %-7.31-638.88-363.20-
Return on Equity %-7.90---
Return on Invested Capital %-3.91--260.31-
Quick Ratio ratio1.310.013.420.02
Current Ratio ratio1.310.013.420.02

Cash flow, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/2022
Net Income-58.17-6.00-1.39-0.78-0.67
Depreciation0.050.01---
Other Funds (Non Cash)42.50-0.11-191.7%0.12+9.1%0.11-50.0%0.22
Funds from Operations-15.62-6.10-1.27-0.67-0.45
Extraordinary Item0.000.000.000.000.00
Changes in Working Capital1.76-2.82-622.2%0.54+1250.0%0.04-0.00
Cash from Operating Activities-13.86-8.93-0.73-0.63-0.45
Capital Expenditures-0.05-0.060.000.000.00
Net Assets From Acquisitions0.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.00
Purchase or Sale of Investments0.00-2.000.000.000.00
Purchase of Investments-2.00-2.000.000.000.00
Sale Or Maturity of Investments2.000.000.000.000.00
Other Uses-8.02-8.020.000.000.00
Other Sources0.020.020.000.000.00
Cash from Investing Activities-8.06-10.060.000.000.00
Cash Dividends Paid0.000.000.000.000.00
Change in Capital Stock-0.3211.630.00-100.0%1.050.00
Repurchase of Common Pref Stock0.000.000.000.000.00
Sale of Common Pref Stock-0.3211.630.00-100.0%1.050.00
Proceedsfrom Stock Options-0.3211.630.00-100.0%1.050.00
Issuance or Reduction of Debt, Net14.029.30+3620.0%0.250.00-100.0%0.26
Change in Long Term Debt8.809.050.000.000.00
Issuance of Long Term Debt8.809.050.000.000.00
Reduction of Long Term Debt0.000.000.000.000.00
Net Financing Active Other Cash Flow-0.24-0.31-487.5%0.08-0.02-200.0%0.02
Other Financing Activities Uses-0.25-0.340.00-0.030.00
Cash from Financing Activities13.4620.62+6148.5%0.33-68.0%1.03+267.9%0.28
Net Change in Cash-8.461.63-0.41-202.5%0.40-0.17
Free Cash Flow-13.92-8.98-0.73-0.63-0.45
Preferred Dividends (Cash Flow)--0.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.00

Balance sheet, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/20242024Q39/30/2024
Cash & Short Term Investments8.28-5.3%10.48+4092.0%11.646.99+23200.0%8.74+14466.7%0.25+66.7%0.00-100.0%0.03-96.0%
Short Term Receivables0.120.000.000.000.000.000.000.00
Inventories0.000.000.000.000.000.000.000.00
Other Current Assets2.28+41.6%2.67+26600.0%2.35+23400.0%2.10+20900.0%1.61+16000.0%0.010.0%0.010.0%0.01-94.1%
Total Current Assets10.68+3.2%13.15+4957.7%13.98+139700.0%9.09+22625.0%10.35+14685.7%0.26+62.5%0.01-97.6%0.04-95.7%
Net Property, Plant & Equipment0.21+2000.0%0.230.240.030.010.000.000.00
Total Investments and Advances0.000.000.000.000.000.000.000.00
Intangible Assets116.74127.82149.890.000.000.000.000.00
Other Assets0.00-100.0%0.020.080.130.180.000.000.00
Total Assets127.62+1109.7%141.22+54215.4%164.18+1641700.0%9.25+23025.0%10.55+14971.4%0.26+62.5%0.01-97.6%0.04-95.7%
Short Term Debt Incl. Current Port. of LT Debt14.47+2794.0%9.41+1417.7%7.63+2952.0%0.50+100.0%0.50+400.0%0.620.250.25-21.9%
Accounts Payable2.090.240.920.000.000.000.000.00
Income Tax Payable-0.01------
Other Current Liabilities4.52+1358.1%4.92+327.8%2.16+180.5%0.59+15.7%0.31-20.5%1.15+721.4%0.77+541.7%0.51+750.0%
Total Current Liabilities21.07+2501.2%14.58+723.7%10.71+950.0%1.09+43.4%0.81+65.3%1.77+1164.3%1.02+750.0%0.76+100.0%
Long Term Debt0.100.12-52.0%0.13-62.9%0.00-100.0%0.00-100.0%0.25-13.8%0.35+29.6%0.32-20.0%
Provision for Risks Charges0.000.000.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.000.000.00
Total Liabilities21.18+2514.8%14.70+627.7%10.84+691.2%1.09+0.9%0.81+2.5%2.02+381.0%1.37+251.3%1.08+38.5%
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.070.070.000.000.000.000.00
Common Equity106.45+992.9%126.44153.278.169.74-1.76-1.36-4633.3%-1.05-800.0%
Total Shareholders Equity106.45+992.9%126.52153.358.169.74-1.76-1.36-4633.3%-1.05-800.0%
Accumulated Minority Interest0.000.000.000.000.000.000.000.00
Total Equity106.45+992.9%126.52153.358.169.74-1.76-1.36-4633.3%-1.05-800.0%
Total Liabilities & Stockholders Equity127.62+1109.7%141.22+54215.4%164.18+1641700.0%9.25+23025.0%10.55+14971.4%0.26+62.5%0.01-97.6%0.04-95.7%
Book Value Per Share per share70.54+811.4%100.54121.886.497.74-2.23-1.16-3966.7%-0.82-845.5%
Tangible Book Value Per Share per share-6.82-188.1%-1.092.696.497.74-2.23-1.16-3966.7%-0.82-845.5%
Full-Time Employees people--7+250.0%---20.0%-
Price to Book Ratio ratio0.030.180.132.742.27-7.99--
Return on Assets %-84.20-57.48-7.31-111.07-69.84-716.40-638.88-342.91
Return on Equity %-100.13-65.18-7.90-144.99-82.20---
Return on Invested Capital %-18.93-27.69-0.75-21.83-27.34---
Quick Ratio ratio0.510.901.318.3412.790.150.010.05
Current Ratio ratio0.510.901.318.3412.790.150.010.05

Cash flow, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/20242024Q39/30/2024
Net Income-20.17-35.06-1.16-1.78-2.66-0.40-0.31-0.33
Depreciation0.020.020.000.00----
Other Funds (Non Cash)13.52+607.9%31.03+77475.0%-2.09-5325.0%0.04+33.3%1.91+9450.0%0.04+33.3%0.04+300.0%0.03+200.0%
Funds from Operations-6.63-4.01-3.24-1.74-0.76-0.36-0.28-0.30
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital0.451.86+447.1%-0.58-422.2%0.02-81.8%-2.60-1183.3%0.34+3300.0%0.18-14.3%0.11
Cash from Operating Activities-6.18-2.14-3.82-1.73-3.36-0.02-0.10-0.19
Capital Expenditures0.00-0.01-0.02-0.02-0.010.000.000.00
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00
Purchase or Sale of Investments1.500.50-2.000.000.000.000.000.00
Purchase of Investments0.000.00-2.000.000.000.000.000.00
Sale Or Maturity of Investments1.500.500.000.000.000.000.000.00
Other Uses0.000.00-8.020.000.000.000.000.00
Other Sources0.000.000.020.000.000.000.000.00
Cash from Investing Activities1.500.49-10.02-0.02-0.010.000.000.00
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Preferred Dividends (Cash Flow)---0.000.000.000.000.00
Change in Capital Stock0.00-100.0%0.00-0.320.0011.950.000.00-100.0%0.00-100.0%
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.00
Sale of Common Pref Stock0.00-100.0%0.00-0.320.0011.950.000.00-100.0%0.00-100.0%
Proceedsfrom Stock Options0.00-100.0%0.00-0.320.0011.950.000.00-100.0%0.00-100.0%
Issuance or Reduction of Debt, Net3.980.99+296.0%9.050.00-100.0%0.00-100.0%0.250.000.15
Change in Long Term Debt0.000.00-100.0%9.05-0.25-266.7%0.00-100.0%0.25-0.250.15
Issuance of Long Term Debt0.000.00-100.0%9.05-0.25-266.7%0.00-100.0%0.25-0.250.15
Reduction of Long Term Debt0.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.00-100.0%-0.24-400.0%0.00-0.090.020.080.00-100.0%
Other Financing Activities Uses0.000.00-0.250.00--0.000.00
Cash from Financing Activities3.98-66.4%0.99+266.7%8.49+10512.5%0.00-100.0%11.86+11760.0%0.270.080.15-85.3%
Net Change in Cash-0.70-108.3%-0.66-364.0%-5.35-1.758.480.25-0.02-0.04-105.3%
Free Cash Flow-6.18-2.15-3.84-1.75-3.37-0.02-0.10-0.19

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-305.68%0.0M0.6M3.70M
2026-10-1513.04%0.1M0.6M3.70M
2026-09-3014.20%0.1M0.6M2.09M
2026-09-151.85%0.0M0.6M74.50K
2026-08-313.56%0.0M0.6M67.72K
2026-08-142.67%0.0M0.6M25.88K
2026-07-314.79%0.0M0.6M30.68K
2026-07-153.12%0.0M0.6M23.60K
2026-06-304.11%0.0M0.6M22.89K
2026-06-152.62%0.0M0.6M21.32K
2026-05-294.46%0.0M0.4M21.12K
2026-05-156.03%0.0M0.3M21.00K
2026-04-302.98%0.0M0.3M4.24K

Option chain

expiry 2026-11-13
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-053Initial statement of beneficial ownership of securities2026-10-01SEC
2026-11-023Initial statement of beneficial ownership of securities2025-12-01SEC
2026-11-023Initial statement of beneficial ownership of securities2025-12-01SEC
2026-10-138-KCurrent report2026-10-04SEC
2026-10-018-KCurrent report2026-09-29SEC
2026-09-298-KCurrent report2026-09-24SEC
2026-09-238-KCurrent report2026-07-24SEC
2026-09-118-KCurrent report2026-09-10SEC
2026-08-218-KCurrent report2026-08-19SEC
2026-08-1410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-068-KCurrent report2026-08-05SEC
2026-07-138-KCurrent report2026-07-13SEC
2026-05-2610-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-15NT 10-Q2026-03-31SEC
2026-05-07SCHEDULE 13D/ASEC
2026-05-058-KCurrent report2026-05-05SEC
2026-05-0410-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-05-048-KCurrent report2026-04-24SEC
2026-04-228-KCurrent report2026-04-17SEC
2026-04-168-KCurrent report2026-04-15SEC
2026-04-09425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-04-098-K/A2026-03-20SEC
2026-03-31NT 10-K2025-12-31SEC
2026-03-30SCHEDULE 13D/ASEC
2026-03-268-KCurrent report2026-03-20SEC
2026-03-258-KCurrent report2026-03-20SEC
2026-03-20SCHEDULE 13D/ASEC
2026-03-168-KCurrent report2026-03-16SEC
2026-02-27DEFM14CInformation Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934SEC
2026-02-17425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Hemenway Trust Co LLC1.82%
UBS Group AG0.43%
VANGUARD CAPITAL MANAGEMENT LLC0.42%
GEODE CAPITAL MANAGEMENT, LLC0.23%
VANGUARD FIDUCIARY TRUST CO0.16%
JANE STREET GROUP, LLC0.11%
Tower Research Capital LLC0.01%
JPMORGAN CHASE & CO0.00%
CITIGROUP INC0.00%

Funds

Fund% owned
VANGUARD EXTENDED MARKET INDEX FUND0.34%
Fidelity Extended Market Index Fund0.32%
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND0.08%
Fidelity Series Total Market Index Fund0.06%

OakChart. APUS. Cached 15 minutes. Terms

Some panels did not load: ratings, insider, news.